Cancer prevention – Parentraide Cancer http://parentraide-cancer.org/ Tue, 11 Jan 2022 08:39:55 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://parentraide-cancer.org/wp-content/uploads/2021/06/icon.png Cancer prevention – Parentraide Cancer http://parentraide-cancer.org/ 32 32 5,000 Nigerien women to benefit from cancer screening and prevention services – Blueprint Newspapers Limited https://parentraide-cancer.org/5000-nigerien-women-to-benefit-from-cancer-screening-and-prevention-services-blueprint-newspapers-limited/ Tue, 11 Jan 2022 07:42:04 +0000 https://parentraide-cancer.org/5000-nigerien-women-to-benefit-from-cancer-screening-and-prevention-services-blueprint-newspapers-limited/ At least 5,000 women are expected to benefit from human papillomavirus (HPV) screening and cervical cancer prevention services in Niger state as part of government efforts to reduce the prevalence of the disease . State Governor Abubakar Sani Bello told Minna on Monday while reporting the exercise at Jummai Babangida Maternal and Newborn Hospital. He […]]]>

At least 5,000 women are expected to benefit from human papillomavirus (HPV) screening and cervical cancer prevention services in Niger state as part of government efforts to reduce the prevalence of the disease .

State Governor Abubakar Sani Bello told Minna on Monday while reporting the exercise at Jummai Babangida Maternal and Newborn Hospital.

He said, “The multi-phased exercise will benefit 5,000 women in nine local government areas of the state as a pilot program. “

He explained that the government is aware of the worrying cancer situation in the state, adding that it is determined to remedy the situation by adhering to the World Organization’s 90-70-90 cancer elimination strategy. health (WHO) in the state.

The governor assured that providing good health facilities and services in the state would continue to be the priority of his administration.

“I am happy to inform you that we have already put in place a mechanism to remedy the situation as well as to achieve the goal set by the World Health Organization (WHO). Our determination is to put in place a program for a cervical cancer-free generation in the State, with the right education, knowledge and the right environment to combat this global threat, ”he said .

He assured that his government would continue to work on improving some of the negative health indices in the state, explaining that the delivery of health care had seen significant changes in his administration.

Also speaking, the governor’s wife, Dr Amina Abubakar Bello, revealed that cervical cancer is the 4th leading cause of death in women, affecting an estimated 1.4 million women worldwide.

The governor’s wife, who is also the founder of the RAiSE Foundation, said the strategies employed to eliminate cervical cancer include vaccination, screening and treatment of precancerous lesions, and treatment through care. palliative.

]]>
How Amber’s tragic death at just 25 helps save other women from cancer https://parentraide-cancer.org/how-ambers-tragic-death-at-just-25-helps-save-other-women-from-cancer/ Sun, 09 Jan 2022 18:00:00 +0000 https://parentraide-cancer.org/how-ambers-tragic-death-at-just-25-helps-save-other-women-from-cancer/ A charity established in memory of a beloved Sunderland woman has launched a new campaign to encourage local women to attend their cervical cancer screening if they are eligible. Amber’s Law was created by Amber Rose Cliff’s family in 2017 when she died of cervical cancer at the age of just 25. With Amber’s birthday […]]]>

A charity established in memory of a beloved Sunderland woman has launched a new campaign to encourage local women to attend their cervical cancer screening if they are eligible.

Amber’s Law was created by Amber Rose Cliff’s family in 2017 when she died of cervical cancer at the age of just 25.

With Amber’s birthday falling on January 8 and Cervical Cancer Prevention Week beginning on January 17, the association has partnered with local businesses to get the message out: ” smears save lives ”.

Go here for the latest NHS news and the latest public health news from Teesside

Darren Cliff is Amber’s father and alongside Amber’s Law volunteers he has led the campaign for the past five years to raise awareness of this “hidden killer” and to preserve Amber’s legacy.

Darren’s partner Kay Attle, 34, from Hartlepool, has been a driving force behind the Teesside charity.

She said: “When Amber was 18, she started to experience the symptoms associated with cervical cancer. So she went to see her GP. As she was under 25, she couldn’t to undergo this important Pap (smear) test, after three years of visits she went for a private smear test which had been booked by her father which led to her diagnosis.

“Unfortunately, it turned out that she had been developing numerous cancerous tumors in her cervix for several years and despite treatment, the cancer spread to her lymph nodes, throat and lungs.”

Amber Rose Cliff died on January 8, 2017 at just 25, the age at which she would be eligible for cervical cancer screening.

January also marks Cervical Cancer Prevention Week, which runs from January 17 to 23. Amber’s Law is launching its new campaign to place A5 stickers in public places in the North East.

They have teamed up with local bars and businesses to display these stickers on the bathroom doors so women can clearly see the message.

The stickers carry the slogan “Pap smear tests save lives” and list common symptoms associated with cervical cancer: unusual bleeding, pain in the lower stomach or pelvis, and discomfort during or after sex. sexual.



Amber’s Law’s latest campaign poster ahead of Cervical Cancer Prevention Week

By teaming up with the national charity Jo’s Trust, they are encouraging women to attend their smear test after statistics showed that one in three people did not show up at all.

Kay added, “Of course, covid has made dating a lot more difficult for a lot of people, but these numbers were staggering and really shocked us.

“I know it might seem embarrassing and a little awkward to take your smear test, but it could ultimately save your life!” Yes, you might feel cold and uncomfortable for about 20 seconds, but if you feel like you don’t need to attend your screening, I invite you to read Amber’s story. “

Amber’s Law has gained national recognition over the past five years, most notably TV promoting Lorraine Kelly and former Prime Minister Theresa May shared Amber’s story in Parliament.

Kay, the youth health and wellness worker, hopes Amber’s story and campaign both during Cervical Cancer Prevention Week and throughout the year may be the driving force needed for change.

Kay said: “One of the main hurdles now is campaigning against the proposed change in Wales where they want to increase the test gap from three to five years, a lot can change in three years let alone five years and we are completely against it.

“Women in the UK are incredibly lucky to have access to a free NHS smear test and I really encourage all eligible women to attend their screening – I assure you there is absolutely nothing to to fear!”

For more information on cervical cancer, Amber’s story, and how to raise awareness, visit amberslaw.org.

For the latest news in your area delivered straight to your inbox every day, go to here to subscribe to our free newsletter


Source link

]]>
I am approaching a “milestone” birthday; what health check-ups should I have at my age? https://parentraide-cancer.org/i-am-approaching-a-milestone-birthday-what-health-check-ups-should-i-have-at-my-age/ Wed, 05 Jan 2022 06:30:33 +0000 https://parentraide-cancer.org/i-am-approaching-a-milestone-birthday-what-health-check-ups-should-i-have-at-my-age/ You’re not alone. Most people wait until they are sick to see a GP, so there is usually not much time in a visit to talk about preventive health as well. So, should you book a check with your GP just to talk about what you can do to stay healthy? And if so, what […]]]>

You’re not alone. Most people wait until they are sick to see a GP, so there is usually not much time in a visit to talk about preventive health as well.

So, should you book a check with your GP just to talk about what you can do to stay healthy? And if so, what should you discuss?

It depends on your stage of life.

Doctors won’t check you for everything

It may surprise you that there is no evidence that a “general checkup” will give you better health outcomes.

Some preventive checks in low-risk, otherwise healthy patients have shown no benefit, including some blood tests and imaging tests, such as whole-body CT scans or MRIs for cancer screening.

Besides being a waste of time and money, generic health screening presents another problem: It can lead to overdiagnosis, which leads to additional tests, appointments, anxiety, medication, and more. even operations. Ironically, it can leave you feeling less healthy.

That’s why doctors don’t “check everything,” but are guided by what you could personally benefit from, based on your personal history, as well as tests to show that the benefits outweigh the harms.

Get preventative check-ups every now and then. (Photo: Getty / Thinkstock)

One of the main considerations for your doctor will be your age.

Young adults (20-30 years old)

The main evidence-based screening test for young adults is the cervical test for women. This is a five-year cervical swab that looks for human papillomavirus (HPV) and precancerous cells.

When young women show up for their Pap smear test, several other important preventative discussions often take place, including pregnancy prevention or planning.

Since young men do not need an equivalent screening test, they often miss the opportunity to talk about prevention.

Men and women in this age group should find a general practitioner with whom they feel comfortable discussing checks for STIs (sexually transmitted infections), skin cancer, mental health issues and intimate partner violence.

Even otherwise, fit and healthy young adults should consider talking to their GP about what they can do to prevent chronic disease over time. Health behaviors such as diet, sleep, smoking, and exercise levels in young adults increase or decrease the risk of developing diseases such as diabetes, heart disease, stroke, and cancer. .

Finally, regular check-ups by dentists and optometrists can detect problems early.

40-50 years

Despite the adage “life begins at 40”, this is the age at which many of the things that can cause premature death are worth considering.

Current evidence shows benefits in measuring your blood pressure, cholesterol, and risk for heart disease, diabetes, kidney disease, and skin cancer.

If you are at higher risk for certain cancers (such as breast or colorectal cancer), screening for these may also start around this age.

It is also not too late to improve your longevity by changing your lifestyle. It is therefore important to discuss things like losing weight, quitting smoking, and improving your physical activity.

check-up, check-up, when to check-up, different check-ups for different age groups, check-up by age, preventive check-up, health and wellness, Indian news express Although annual generic “check-ups” are not recommended, a conversation with your GP will help you determine your specific health risks. (Photo: Getty / Thinkstock)

As with young adults, women should continue to have a Pap smear every five years.

And everyone should consider getting checked out by a dentist and optometrist.

Mental health can deteriorate at this age as well, as the strain of caring for children, aging parents, and demanding careers can all come to a head. The advice of a psychologist can be helpful.

50-65 years

Patients often comment on the 50th “birthday present” they find in the mail: a stool sample collection kit for colorectal cancer screening. While not the peak of your 50s, it is effective in saving lives by detecting this cancer early, with checkups recommended every two years.

Women will also be asked to start mammograms for breast cancer screening every two years (unless they have already started in their 40s, depending on their individual risk).

The third health problem to look for in your 50s is osteoporosis, a disease in which the bones become weak and the risk of fractures increases. Osteoporosis is painless and is therefore often not discovered until too late. You can start checking your risk at home through an online calculator, like the one from the Garvan Institute.

Oral health and eye exams also remain important in this age group.

Over 65

Several vaccines are recommended from the age of 65, including shingles and the flu, because your immunity begins to decline and your risk of serious illness increases.

check-up, check-up, when to check-up, different check-ups for different age groups, check-up by age, preventive check-up, health and wellness, Indian news express Dental health is also part of preventive health care. (Photo: Getty / Thinkstock)

Other preventive checks include those of your vision, dental health, hearing, and risk of falling. These often involve paramedical providers who can screen you, monitor, and treat you as needed.

Some of your other regular screenings will stop in the mid-1970s, especially for colorectal, cervical and breast cancer.

First Nations peoples

The above age-related recommendations are for people with standard risk factors. First Nations Australians are at higher risk of developing a range of illnesses, including diabetes, heart disease, kidney disease, and some cancers.

Aborigines and Torres Strait Islanders may be offered more in-depth screening, on a different schedule, with some checks at an earlier age.

Although annual generic “check-ups” are not recommended, a conversation with your GP will help you determine your specific health risks and screening needs.

Prevention is better than cure, so make sure you have access to the evidence-based screening and prevention strategies that are right for you.

?? For more lifestyle news, follow us on Instagram | Twitter | Facebook and don’t miss the latest updates!



Source link

]]>
Smoking increases the risk of stomach cancer: Dr Vikas Roashan https://parentraide-cancer.org/smoking-increases-the-risk-of-stomach-cancer-dr-vikas-roashan/ Mon, 03 Jan 2022 18:40:48 +0000 https://parentraide-cancer.org/smoking-increases-the-risk-of-stomach-cancer-dr-vikas-roashan/ Gastrointestinal (GI) cancer is an umbrella term used to describe cancers that affect the digestive system. It includes colorectal cancer (CRC), gastric cancer, liver cancer, esophageal cancer, and pancreatic cancer. It has been reported to be a very common malignant tumor in Kashmir. In conversation with Rising Kashmir’s health correspondent Pair of Mansour, Senior Consultant […]]]>

Gastrointestinal (GI) cancer is an umbrella term used to describe cancers that affect the digestive system. It includes colorectal cancer (CRC), gastric cancer, liver cancer, esophageal cancer, and pancreatic cancer. It has been reported to be a very common malignant tumor in Kashmir.

In conversation with Rising Kashmir’s health correspondent Pair of Mansour, Senior Consultant at the American Oncology Institute (AOI) Acharya Shri Chander College of Medical Sciences (ASCOMS) Jammu, Dr Vikas Roashan, talks about the causes, symptoms, detection, treatment and impact of cancer of the gastrointestinal tract.

Extracts!

What is gastrointestinal cancer?

Cancer of the gastrointestinal tract is an umbrella term used to describe cancers that affect the digestive system. It includes colorectal cancer (CRC), gastric cancer, liver cancer, esophageal cancer, and pancreatic cancer. Less common gastrointestinal cancers include those affecting the anus, appendix, bile ducts, gallbladder and small intestine, gastrointestinal neuroendocrine tumors (NETs) and stromal tumors (GIST), which occur are distinguished by their original cell type.

What are its risk factors?

Certain factors increase the risk of stomach cancer: gastroesophageal reflux disease (GERD), obesity, increased salt intake and high consumption of smoked foods, less consumption of fruits and vegetables, family history of malignant tumors, Helicobacter infection pylori, inflammation of the stomach, smoking, alcohol and polyps.

What are the ways to prevent it?

Fruits and vegetables should be added to the diet every day. Choose a wide variety of colorful fruits and vegetables. Maintain a healthy weight. If you are obese, try to strategize to lose weight. Try to plan exercises to reduce weight. The recommended exercise time is 150 minutes per week.

Cut down on salt and smoked foods. Protect your stomach by limiting these foods. These foods contain harmful chemicals which lead to the development of cancer.

What is the role of smoking in gastrointestinal cancer? Is this a contributing factor?

Smoking increases the risk of stomach cancer, as well as many other types of cancer. Quitting smoking is very difficult, so ask your doctor for advice. Quitting smoking requires medical advice and help.

Should people with a strong family history of stomach cancer consider tests, such as endoscopy, to look for signs?

The stomach has a lot of space, so in the early stages of stomach cancer, many patients have little or no symptoms. For this reason, stomach cancer is difficult to detect and doctors often detect the disease at more advanced stages because at this stage it is more difficult to treat.

A team of stomach cancer experts will use a variety of tools and tests designed to diagnose stomach cancer, assess the disease, and develop your personalized treatment plan.

In addition, laboratory tests will be done throughout your treatment and imaging tests will be used to examine your response to treatment and modify your plan if necessary.

How long does it take to develop stomach cancer?

The doubling time for stomach cancer is about 11 months for early lesions and six months for advanced stages. In three years, early stomach cancer progresses to advanced cancer. In the early stages, 50% of patients survive.

What should a patient do if he is diagnosed with such cancer?

After the initial diagnosis, the patient should undergo blood tests, local endoscopy, metastatic evaluation to see if the disease is localized or metastatic, and finally, depending on the histopathology, treatment is started. The patient should eat well during treatment and maintain a healthy weight.

What advice should be given to the general population to avoid stomach / stomach cancer?

The message to the masses is to avoid risk factors like smoking, reduce alcohol intake, maintain weight, increase fruits and vegetables in the diet, and exercise regularly.

Are there many myths in society about cancer patients? What is your message to the people?

There is a common myth that we should reduce sugar intake during cancer treatment because cancer uses sugar for growth, but it is not; carbohydrates should be taken according to body weight and needs. They are just patients. We need to give them more love and care.

How to reduce the burden of cancer?

Thirty to fifty percent of cancers can be prevented by avoiding risk factors and implementing existing evidence-based prevention strategies. The burden of cancer can also be reduced with early detection of cancer and appropriate treatment and care for patients who develop cancer. Many cancers have a good chance of being cured if they are diagnosed early and treated appropriately.

What treatment is available at J&K for stomach cancer?

There are different types of treatment modalities for patients with stomach cancer. Seven types of treatment are used for the management of stomach cancer, including surgery, endoscopic mucosal resection (EMR), chemotherapy, radiation therapy, radiochemotherapy, targeted therapies, and immunotherapies.

New treatment techniques are being tested in different clinical trials (not available in J&K).

Some treatments are standard (those currently in use), and some are tested in clinical trials. A clinical trial is a study aimed at improving current treatment programs or obtaining vital information about new treatment techniques for cancer patients. When clinical trials show that a new treatment is better than the standard treatment, the new treatment can become the standard treatment. Therefore, patients may want to consider participating in a clinical trial. Some clinical trials only recruit patients who have not received cancer treatment.

Different types of treatments available to patients

Operation

Surgery is a common treatment technique for all stages of gastric cancer. The following types of surgery can be used:

• Subtotal gastrectomy when a surgeon removes part of the stomach containing cancer, nearby lymph nodes, and parts of other tissues and organs near the tumor.

• Total gastrectomy involves the removal of the entire stomach, nearby lymph nodes, and parts of the digestive tract, small intestine, and other tissue near the tumor.

If the tumor is blocking the stomach, but the cancer cannot be completely removed with standard surgery, the following techniques can be used:

Ø Stent placement: a technique for inserting a stent (a thin, stretchable tube) to keep a passage (such as arteries or esophagus) open. For tumors that block the passage of the stomach, the operation may involve placing a tube from the digestive tract to the stomach or from the stomach to the small intestine to help the patient eat normally and maintain weight.

Ø Endoluminal laser therapy: This is a procedure in which an endoscope (light tube) with a laser attached to it is inserted into the body. This laser will act like a knife to remove the cancer.

Ø Gastrojejunostomy: a procedure in which part of the stomach along with the cancer is removed, which blocks the passage and the ends are connected. This allows food and medicine to pass from the stomach to the small intestine.

Endoscopic mucosal resection (EMN)

Endoscopic mucosal resection is a technique that uses an endoscope to remove early-stage cancer from the inner lining of the digestive tract. An endoscope is a thin tube with a light source and a lens for viewing.

Chemotherapy

Chemotherapy is a technique for treating cancer that uses drugs to stop the proliferation of cancer cells. It stops the growth of cancer by killing cancer cells. Chemotherapy is usually given intravenously (through the vein via a drip) or by mouth. The drug reaches the tumor through the bloodstream. Chemotherapy is given depending on the stage, the severity of the disease and the type of cancer being treated.

Sometimes regional chemotherapy is used, also called intraperitoneal chemotherapy. Cancer drugs are placed directly into the peritoneal space through the tubes in intraperitoneal chemotherapy.

Surgeons use HIPEC after completing surgery in which heated chemotherapy is given directly into the peritoneal cavity.

Radiotherapy

Radiation therapy is a cancer treatment technique that uses high-energy X-rays or other types of radiation to treat cancer. It works by killing tumor cells; there are two techniques for administering radiotherapy, external radiotherapy and brachytherapy. For gastrointestinal cancers, generally, EBRT is used.

Chemoradiotherapy

Sometimes radiation therapy is combined with chemotherapy to enhance the effect of both modalities. This technique improves the action of radiation.

Chemoradiation therapy can be added before or after surgery for cancer management. It is given after surgery to reduce the risk of local recurrence. When given before surgery, chemotherapy helps shrink the tumor and helps the surgeon remove the cancer.

Targeted therapy

In targeted therapy, drugs are used to identify and attack specific cancer cells. Targeted therapies generally cause less damage to normal cells than chemotherapy or radiation therapy. Monoclonal antibodies and multi-kinase inhibitors (IMKs) are types of targeted therapy used in the treatment of stomach cancer.

Monoclonal antibodies

Monoclonal antibodies made in the laboratory to treat many diseases, including cancer. As a treatment for cancer, these proteins can attach to a particular target on cancer cells, which can help cancer cells to grow. Antibodies can kill cancer cells, block their growth, or stop them from spreading. Monoclonal antibodies are administered intravenously. Targeted therapy can be used on its own and sometimes in combination with other carrier drugs, chemotherapy, or radioactive materials.

There are different types of monoclonal antibodies

· Trastuzumab (Herceptin) blocks the effect of the growth factor protein HER2, which sends regulatory growth signals to gastric cancer cells.

Ramucirumab blocks the effect of specific proteins, including vascular endothelial growth factors. It can help control cancer cells and can kill cells as well. It also prevents the growth of new blood vessels that cancer needs to grow.

Trastuzumab and ramucirumab are used to treat stage IV gastric cancer and gastric cancer that cannot be removed with surgery or has come back.


Source link

]]>
Ask the Doctors: Prolonged Use of Baby Aspirin Depends on Age | Various https://parentraide-cancer.org/ask-the-doctors-prolonged-use-of-baby-aspirin-depends-on-age-various/ Sun, 02 Jan 2022 05:15:00 +0000 https://parentraide-cancer.org/ask-the-doctors-prolonged-use-of-baby-aspirin-depends-on-age-various/ Dear doctors: The recommendation against taking baby aspirin every day seems to pit the prevention of heart disease against the risk of bleeding. But it doesn’t include the potential benefits of aspirin in reducing colon cancer. How should people consider the benefit of colon cancer? Who makes these recommendations? Dear reader: You’re referring to a […]]]>

Dear doctors: The recommendation against taking baby aspirin every day seems to pit the prevention of heart disease against the risk of bleeding. But it doesn’t include the potential benefits of aspirin in reducing colon cancer. How should people consider the benefit of colon cancer? Who makes these recommendations?

Dear reader: You’re referring to a new draft guideline, presented by members of the US Preventive Services Task Force, on the use of low-dose aspirin to prevent heart disease and stroke. They suggest that the daily diet should no longer be routinely recommended for older people who are not at high risk. The reasoning is that the potential protective cardiovascular benefits are outweighed by the risks of bleeding, which increase as people age. These proposed changes would not apply to patients who have had a previous heart attack or stroke, or to people already taking low-dose aspirin under the care of a doctor. If the guidelines are approved, patients using low-dose aspirin will be advised to check with their doctor to see if any changes are warranted.

Turning to the daily use of low-dose aspirin to reduce the risk of heart attack and stroke, the panel returns to a topic that has always been controversial. This is for the reason you mention in your letter. That is, the use of low dose aspirin is essentially an exercise in risk tolerance. The main use of aspirin is as a pain reliever. But it’s also a blood thinner, and taking it regularly can reduce the likelihood of developing a blood clot. However, it is also known that even in low doses aspirin can cause gastrointestinal bleeding. This is more and more true as people get older. So, when a person follows a daily regimen of low-dose aspirin, they balance the potential cardiovascular benefits with the risk of bleeding, which can have its own negative health consequences.


Source link

]]>
Helix BioPharma Corp. take stock of the company https://parentraide-cancer.org/helix-biopharma-corp-take-stock-of-the-company/ Fri, 31 Dec 2021 12:33:45 +0000 https://parentraide-cancer.org/helix-biopharma-corp-take-stock-of-the-company/ Enter Wall Street with Street Insider Premium. Claim your 1-week free trial here. RICHMOND HILL, ON / ACCESSWIRE / December 31, 2021 / Helix BioPharma Corp. (TSX: HBP) ​​(“Helix” or the “Company”), an immuno-oncology company that develops innovative drug candidates for the prevention and treatment of cancer, is pleased to provide an update on initiatives […]]]>

Enter Wall Street with Street Insider Premium. Claim your 1-week free trial here.


RICHMOND HILL, ON / ACCESSWIRE / December 31, 2021 / Helix BioPharma Corp. (TSX: HBP) ​​(“Helix” or the “Company”), an immuno-oncology company that develops innovative drug candidates for the prevention and treatment of cancer, is pleased to provide an update on initiatives undertaken by the Company in 2021.

Despite the challenges posed by the COVID-19 pandemic, 2021 has been a productive year for the Company. During the second half of 2021, the Company initiated efforts to validate Helix and its core clinical program with external stakeholders to provide an outside perspective on the strategy and future of the company, including, but without limitation, the following actions:

  • In May 2021, Helix retained the consulting services of Dr. Christof Boehler, PhD, a seasoned biotechnology scientist and entrepreneur to evaluate Helix and its assets. The result of this engagement has been a positive outlook on the potentials of L-DOS47, which has been shown to be safe in approximately 100 patients to date in the Company’s Phase 1 clinical trials. Given the limitations of the current standard of care for meeting the high unmet medical needs in oncology, the Company believes that the unique characteristics of L-DOS47 position Helix as one of the leaders in the development of new avenues such as microenvironments. (change in tumor pH), with the aim of improving the results of the treatment of various malignancies with the use of L-DOS47 in combination with immunotherapy and / or chemotherapy.
  • In addition to Dr. Boehler’s assessment, Helix also retained the services of a very experienced oncology consulting firm, Cello Healthcare (“Cello“), in August 2021. A major aspect of this engagement included interviews with some key opinion leaders in the field to obtain their comments and recommendations on the Company’s L-DOS47 technology platform. The outcome of these interviews conducted by Cello both validated the clinical work performed by Helix to date, and also helped the Company identify additional opportunities to strengthen and reduce the risks of the Company’s clinical program, including optimal patient selection for trials (stratification) based on objective biomarkers, among other criteria. that these activities will facilitate strategic dialogue with potential leaders in the cancer treatment market, and that the additional preclinical data obtained will further improve the design of the clinical program of the society.
  • Finally, in September 2021, Helix retained the advisory services of Dr Atul Deshpande, PhD, MBA, another seasoned biotechnology executive who helped his former employer, an immuno-oncology company, raise significant funds from venture capital fund and to design a strategy and execution plan with a view to the Company’s IPO and significant concomitant financing. In his role as a consultant, Dr Deshpande has been tasked with implementing a business strategy and updated clinical plans to help the Company achieve its goals.

Dr Slawomir Majewski, CEO and Interim Director, said “We hope that this type of external validation combined with internal expertise and experience will allow Helix to remain focused on advancing towards the development of unique therapies in the field of immuno-oncology for the treatment of cancer. We will continue to partner with these seasoned advisors and subject matter experts to increase the value of our platform and assets.

“Our clinical program remains our top priority to ensure we deliver a substantial data set that would ultimately benefit patients and stakeholders. We are awaiting final trial reports from Phase I and II studies in lung cancer in 2022. The other clinical trial in pancreatic cancer is continuing and we remain committed to this study. Additionally, in May 2021, we announced an agreement with Lind Global Macro Fund, LP, and subsequently closed a first tranche of funding for gross proceeds of $ 3,500,000. We are also working diligently to identify potential candidates for the position of permanent CEO of the Company, ”continued Dr. Majewski.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology for the prevention and treatment of cancer based on our proprietary DOS47 technology platform. Helix is ​​listed on the Toronto Stock Exchange under the symbol “HBP”.

For more information please contact:
Helix BioPharma Corp.
9120 Leslie Street, Suite 205
Richmond Hill, Ontario, L4B 3J9
Phone. : 905-841-2300 ext 233
Frank Michalargias, Chief Financial Officer
ir@helixbiopharma.com

Forward-looking statements and risks and uncertainties

This press release contains forward-looking statements and information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. Forward-looking statements are statements and information that are not historical facts, but rather include financial projections and estimates, statements regarding plans, goals, objectives, intentions and expectations regarding the business, operations, the future research and development of the Company, including the business of the Company. regarding DOS47, and statements regarding the Company’s belief that it is positioned as a leader in the treatment of new cancer treatment pathways, the belief that the Company’s recent actions will provide opportunities to reduce the risks of the clinical program of the Company and enhance the value of the Company’s platform and assets, expectations regarding dialogue with market leaders, expectations regarding improved clinical program design, expectations regarding clinical trial schedule and the results of these tests, and statements concerning the identification and appointment of a permanent general manager. Forward-looking statements may be further identified by the use of forward-looking terminology such as “current”, “estimates”, “expect”, or the negative thereof or any other variation thereof or comparable terminology referring to future events or results, or that events or conditions “will”, “may”, “could” or “should” occur or be achieved, or comparable terminology referring to events or future results.

Forward-looking statements are statements about the future and are inherently uncertain and are necessarily based on a number of estimates and assumptions which are also uncertain. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve risks and uncertainties, and one should not place undue reliance on such statements. Forward-looking statements, including the financial outlook, are intended to provide information about management’s current plans and expectations regarding future operations, including, without limitation, future funding requirements, and may not be suitable for other purposes. Certain important factors, estimates or assumptions have been applied in making forward-looking statements in this press release, including, but not limited to, the ability of the Company to file annual documents within the time frame described herein.

The actual results of the Company could differ materially from those anticipated in the forward-looking statements contained in this press release due to numerous known and unknown risks and uncertainties, including, without limitation, the risk that the Company may not be able to file annual documents. within the proposed timeframe; the risk that the Company’s assumptions may prove to be incorrect; the risk that additional funding may not be obtained in a timely manner, if at all, and that clinical trials may not start or end on time or on budget or fail; third-party suppliers of necessary services or pharmaceuticals and other materials may not function or be unwilling or unable to supply the Company, which could delay or cancel the Company’s research and development activities; necessary regulatory approvals may not be granted or may be withdrawn; the Company may not be able to obtain the necessary strategic support from its partners; general economic conditions, intellectual property and insurance risks; changes in business strategy or plans; and other risks and uncertainties mentioned elsewhere in this press release, each of which could cause actual results to differ materially from current results or anticipated future results of the Company. Some of these risks and uncertainties, and others affecting the Company, are described in more detail in the Company’s annual management report for the year ended July 31, 2021 under the heading “Risks and uncertainties” and the annual information form. Helix, in particular under the headings “Forward-Looking Statements” and “Risk Factors” and other reports filed under the Company’s profile on SEDAR at www.sedar.com sometimes. Forward-looking statements and information are based on the beliefs, assumptions, opinions and expectations of Helix management as of the date of this new press release, and the Company assumes no obligation to update any forward-looking statements or information if such beliefs , assumptions, opinions or expectations, or other circumstances change, except as required by law.

THE SOURCE: Helix BioPharma Corp.

See the source version on accesswire.com:
https://www.accesswire.com/680340/Helix-BioPharma-Corp-Provides-Corporate-Update


Source link

]]>
HPV vaccine dramatically reduces risk of cervical cancer https://parentraide-cancer.org/hpv-vaccine-dramatically-reduces-risk-of-cervical-cancer/ Thu, 30 Dec 2021 08:05:09 +0000 https://parentraide-cancer.org/hpv-vaccine-dramatically-reduces-risk-of-cervical-cancer/ A study from the UK provides further concrete evidence that vaccination against the human papillomavirus (HPV) significantly reduces the risk of cervical cancer. As reported in The Lancet, the analysis found that vaccination at the age of 12 or 13, along with regular screening, reduced the risk of cervical cancer by almost 90% in women […]]]>

A study from the UK provides further concrete evidence that vaccination against the human papillomavirus (HPV) significantly reduces the risk of cervical cancer. As reported in The Lancet, the analysis found that vaccination at the age of 12 or 13, along with regular screening, reduced the risk of cervical cancer by almost 90% in women in their 20s.

“It’s a historic moment to see the first study showing that the HPV vaccine has and will continue to protect thousands of women from developing cervical cancer,” said Michelle Mitchell, Chief Executive Officer of Cancer. Research UK, which funded the study.

HPV is one of the most common sexually transmitted infections, and most people get some of the more than 100 known types of viruses soon after being sexually active. HPV triggers abnormal cell growth which can lead to genital and anal warts, precancerous cell changes and, if not detected and treated, cancer of the cervix, anus, vulva , vagina, penis, mouth and throat (oropharyngeal cancer). About 14,000 new cervical cancer diagnoses and 4,000 deaths occur each year in the United States. Routine screening using Pap smears and HPV tests can detect abnormal cell changes before they progress to invasive cancer.

The Gardasil 9 vaccine, approved in 2014, protects against the two main carcinogenic HPV types (16 and 18), five other high-risk types, and two types (6 and 11) that cause genital and anal warts. The original Gardasil quadrivalent vaccine, which targeted four types of HPV (6, 11, 16 and 18), was approved for young women in 2006 and for young men in 2011. The bivalent Cervarix vaccine targets HPV types 16 and 18 only.

Vaccines are most effective if they are given before a person becomes sexually active. The Centers for Disease Control and Prevention (CDC) recommends Gardasil 9 for girls and boys aged 11 or 12, with catch-up vaccination for those up to 26. The Food and Drug Administration has approved the vaccine for women and men up to age 45; the CDC advises people between the ages of 27 and 45 to talk to their doctor to see if they could still benefit.

Previous research has shown that HPV vaccines are effective in preventing HPV infection, genital warts, and precancerous changes in cervical cells. But since vaccines have only been introduced in the past two decades, it is only recently that it has been possible to demonstrate their effectiveness against cervical cancer itself, which can take years to develop.

A Swedish study published last year showed that the quadrivalent vaccine reduced the risk of cervical cancer by 63% in young women in general and by 88% in those vaccinated before the age of 17. And a recent US study found that between January 2001 and December 2017, the incidence and mortality of cervical cancer declined further in the 15-24 year old cohort – those who were eligible for vaccination at. adolescence – than in older groups.

Peter Sasieni, PhD, King’s College London, and colleagues analyzed registry data on all cervical cancer cases diagnosed in women aged 20-64 in England between January 2006 and June 2019 The Cervarix vaccine has been offered to girls aged 11 to 13 in the UK since 2008, with a catch-up program for ages 14 to 18. Vaccination rates were generally high: 85% of women eligible for vaccination between 12 and 13 years old were fully vaccinated, as were 73% of those eligible between 14 and 13 years old. 16 and 45% of eligible people aged 16 to 18.

During the study period, there were 318,058 diagnoses of advanced precancerous cell changes (cervical intraepithelial neoplasia, or CIN) and 27,946 diagnoses of cervical cancer.

Researchers found that the HPV vaccine reduced the incidence of cervical cancer by 34% for young women who received it between 16 and 18 years old, by 62% for those who were vaccinated between 14 and 16 years old. and 87% for those who had been vaccinated at an advanced age. 12 to 13 years compared to older groups who were not eligible for vaccination. The advanced CIN fell by 39%, 75% and 97%, respectively.

The team estimated that the UK vaccination program prevented 17,235 cases of advanced CIN and 448 cases of cervical cancer over 11 years. Based on these figures, Sasieni predicted that vaccination could reduce cases of cervical cancer in women under 30 to around 50 per year, compared to more than 400 per year before vaccination.

The smaller risk reduction for people vaccinated at an older age is attributed to a lower dose of vaccine in these age cohorts and more women becoming sexually active, and therefore exposed to HPV, prior to vaccination. vaccination. Although the vaccine is effective in preventing HPV infection, it does not eliminate the virus after infection.

“It’s amazing to see the impact of the HPV vaccination, and now we can prove that it has prevented hundreds of women from developing cancer in England,” Sasieni said in a Cancer Research press release. UK. “We have known for many years that the HPV vaccination is very effective in preventing certain strains of the virus, but seeing the real impact of the vaccine has been truly rewarding. Assuming most people continue to be vaccinated against HPV. HPV and getting tested, cervical cancer will become a rare disease. “

Based on these results, Sasieni told the BBC, HPV testing protocols should be reassessed, with continued testing every few years for age groups who were not vaccinated when they were young. and screening maybe two to three times in their lifetime for those vaccinated.

Many remain unprotected

In the UK, a study adds to the evidence that HPV vaccines are very effective against cervical cancer and that they should prevent oral cancer as well. But many people remain unprotected for a variety of reasons.

Despite the UK’s universal free vaccination program, vaccination has not quite reached the World Health Organization’s 90% target. In the United States, a recent CDC survey found that 75% of teens aged 13 to 17 had received at least one dose of HPV vaccine and 59% were fully immunized by 2020. Immunization rates are still lower in many low- and middle-income countries. .

Barriers to HPV vaccination include availability, cost, socio-economic and racial disparities, and the belief that adolescents who are not sexually active do not need the vaccine or that the vaccine will make adolescents more susceptible to have sex. The COVID-19 pandemic has also hampered efforts to provide HPV vaccines and other vaccines to children and adolescents.

A recent modeling study predicted that cervical cancer could be all but eliminated in wealthier communities in the United States by 2030, but it could take another 14 years in communities with high poverty rates. However, lead author Jennifer Spencer, PhD, of the University of Texas at Austin, suggested the disparity was not due to differences in vaccination rates – which were similar in low and high areas. poverty – but rather to differences in screening rates, other social determinants of health, and a higher prevalence in high poverty areas of carcinogenic HPV types that are not covered by vaccines.

In addition, misperceptions about the safety of the HPV vaccine also appear to be a growing problem. A recent study found that almost a quarter of parents cited safety concerns as the main reason for not getting their teens vaccinated. The proportion of parents who mentioned safety concerns increased by 80% between 2015 and 2018, although reports of adverse events actually declined during the same period. Some experts fear that the politicization of COVID-19 vaccines could escalate into increased resistance to HPV vaccination.

State laws that allow adolescents to consent to HPV vaccination without parental consent could increase vaccination rates. Reducing the number of vaccine doses required may also help. Currently, the CDC recommends two doses for people who start the series before the age of 15 and three doses for those who do so later. But a recent study in Kenya found that one dose of the vaccine offered as much protection as several doses for women aged 15 to 20. A single dose of Gardasil 9 or Cervarix reduced infection with HPV types 16 and 18 by 98%.

Click here to read the UK study summary.
Click here to learn more about cervical, anal and oral cancer.



Source link

]]>
MLK Committee Announces Return of Weekend Celebrations https://parentraide-cancer.org/mlk-committee-announces-return-of-weekend-celebrations/ Mon, 27 Dec 2021 11:05:23 +0000 https://parentraide-cancer.org/mlk-committee-announces-return-of-weekend-celebrations/ The Sarasota MLK Celebration Committee is delighted to announce the return of a program of weekend events and activities that commemorates the life and legacy of beloved Civil Rights Leader Reverend Martin Luther King Jr. The celebration will begin with the inauguration of the First Home Bank on January 14. Events will conclude on January […]]]>

The Sarasota MLK Celebration Committee is delighted to announce the return of a program of weekend events and activities that commemorates the life and legacy of beloved Civil Rights Leader Reverend Martin Luther King Jr.

The celebration will begin with the inauguration of the First Home Bank on January 14. Events will conclude on January 17 with the Dr. Martin Luther King Jr. Memorial Breakfast and Community Awards, followed by the Historic Unity Walk and Celebration, which will be hosted at the Robert L. Taylor Community Complex.

Dr King was born on January 15, 1929, and was the country’s foremost leader in the 20th century civil rights struggle. The schedule:

Friday January 14 from 10 a.m. to 4 p.m .: The inauguration of the First Home Bank in Newtown. Located at 1782 Dr. MLK Way in Sarasota, First Home Bank in Newtown will serve as a one-of-a-kind loan production office and financial resource center. The event will include a food truck, refreshments, cash prizes and musical entertainment. First Home Bank will also be open on January 15 from 9 a.m. to 3 p.m.

Jetson Grimes is chairman of the MLK Celebration Committee.

Saturday January 15 from 10 a.m. to 2 p.m .: Sarasota Health Salon, 1781 Dr. MLK Way, Sarasota. Organized by the Gulf Coast Medical Society, Jetson Grimes and the Sarasota MLK Celebration Committee, the health fair will showcase 20 health-related resources such as flu shot administration, ambulance visits, cancer screenings. prostate and cancer prevention services provided by Shots in Arms Coalition, CenterPlace Health, the Florida Department of Health in Sarasota, and the Multicultural Health Institute.


Source link

]]>
Pushing for more dollars for skin cancer research https://parentraide-cancer.org/pushing-for-more-dollars-for-skin-cancer-research/ Sat, 25 Dec 2021 22:03:04 +0000 https://parentraide-cancer.org/pushing-for-more-dollars-for-skin-cancer-research/ Investing in skin cancer prevention not only saves lives, but could also drastically reduce Australia’s nearly $ 2 billion treatment bill, experts say. While systemic treatments for melanoma cost the federal government around $ 500 million in 2020-2021, recent data shows that those for much less fatal but more common keratinocyte cancers represent an annual […]]]>

Investing in skin cancer prevention not only saves lives, but could also drastically reduce Australia’s nearly $ 2 billion treatment bill, experts say.

While systemic treatments for melanoma cost the federal government around $ 500 million in 2020-2021, recent data shows that those for much less fatal but more common keratinocyte cancers represent an annual burden of $ 1.3 billion.

The findings are contained in a new article describing recent studies on the economics of skin cancer prevention published in the peer-reviewed journal Public Health Research and Practice.

Lead author, Associate Professor Louisa Gordon of the QIMR Berghofer Medical Research Institute, says the huge financial tax exists despite the fact that most cancers are preventable and curable.

Despite this, there has been no national investment in skin cancer prevention in Australia for over a decade.

The review, which analyzed evidence from two Australian studies, shows that primary prevention interventions are highly cost-effective: every dollar spent on prevention pays back two to four times the investment.

He also found that regular sun protection was more effective in reducing skin cancer in the general population than early detection through mass screening.

“What our article shows is that while skin cancer is a major burden on our health care system, prevention works,” said Professor Gordon.

“It’s a very important reminder to put on your hat and sunscreen when you go to the beach this summer. “

She says further assessment is needed of the relative benefits of the measures, including workplace shading, personal protective clothing and protective school clothing.

Another way to increase protection could be regulations to lower the price of approved sunscreen products, given that the average Australian only uses 33 teaspoons of sunscreen per year, or less than one. per week.

The study authors noted that one teaspoon of sunscreen only protects one limb for two hours.

Public Health Research and Practice is published quarterly online by the Sax Institute.


Source link

]]>
Russian scientists develop new, more efficient way to detect cancer cells in blood https://parentraide-cancer.org/russian-scientists-develop-new-more-efficient-way-to-detect-cancer-cells-in-blood/ Fri, 24 Dec 2021 11:25:25 +0000 https://parentraide-cancer.org/russian-scientists-develop-new-more-efficient-way-to-detect-cancer-cells-in-blood/ Scientists have found the parameters of the laser radiation at which melanoma cells generate ultrasound signals, according to a study published in the journal Scientific Reports. The study will analyze a large amount of blood and even detect cancer at an early stage. Scientists at Saratov State University in Russia have developed this new, highly […]]]>

Scientists have found the parameters of the laser radiation at which melanoma cells generate ultrasound signals, according to a study published in the journal Scientific Reports. The study will analyze a large amount of blood and even detect cancer at an early stage.

Scientists at Saratov State University in Russia have developed this new, highly effective method that detects cancer cells in the blood. According to the researchers, about 90 percent of cancer deaths are linked to the formation of metastases. Let us let you know that when a tumor grows in any part of the body, it quickly makes cells. These cells enter the bloodstream. After that, these cells reach other parts of the body and form new tumors. This is called metastasis.

The primary tumor is often successfully removed with surgery, but non-metastatic cancer is curable. In such a situation, it is necessary to detect cancer cells in the patient’s blood as early as possible.

Here is how the procedure goes:

In this procedure, a blood sample is placed in a flow cytometry which passes blood cells through a laser beam one cell at a time and the response is analyzed.

This process measures blood cells and helps the doctor make the diagnosis. Artificial cancer cells have been developed which produce a sound similar to cancer cells.

Between 30 and 50 percent of cancers can now be prevented by avoiding risk factors and using evidence-based prevention strategies. Finding cancer early, along with the right treatment and care for patients who develop cancer, can help reduce the burden of cancer. Many cancers have a good chance of being cured if caught early and treated properly.

When cancer is caught early, it is more likely to respond to treatment, resulting in a greater chance of survival, less morbidity, and less expensive treatment. By detecting cancer at an early stage and avoiding delays in treatment, the lives of cancer patients can be dramatically improved.

Read all the latest news, breaking news and news on the coronavirus here.


Source link

]]>